reduce insulin dose when starting glp-1 receptor agonist Agonists: An Alternative for Rapid-Acting Insulin? Algorithm for insulin titration in

G., Livingstone, R

Volpe S, Lisco G, Racaniello D, Fanelli M, Colaianni V, Vozza A, et al

Undoubtably, dysregulation of these peptide systems contributes to overweight, disproportion in body composition, obesity and eating disorders

The platform is still building its reputation, so reviews are limited, but early patient feedback has been positive

doi: 10.1370/afm

City Fertility, Australia Kim Hopkins, PCOS Challenge: National Polycystic Ovary Syndrome Association, USA Angelica Lindn Hirschberg, Karolinska Institutet, Karolinska University Hospital, Sweden Tuong Ho, HOPE Research Centre, My Duc Hospital, Vietnam Kathleen Hoeger, University of Rochester, USA Cailin Jordan, Genea Hollywood Fertility, Australia Richard S